Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.
Aplastic Anemia, MDS, and PNH Awareness Week: March 1 - 8
You’re invited to celebrate with us! Find how you can participate here:
Aplastic Anemia Myelodysplastic Syndromes (MDS) Paroxysmal Nocturnal Hemoglobinuria (PNH)